<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Yildirim Clemensen | Activity</title>
	<link>https://recash.wpsoul.net/members/divingtable0/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/divingtable0/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Yildirim Clemensen.</description>
	<lastBuildDate>Wed, 20 May 2026 17:00:04 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">27f33944c2a3f72c0dd02377f7cc9b37</guid>
				<title>Yildirim Clemensen posted an update: Multiple studies confirm that PARP inhibitors play an [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/50813/</link>
				<pubDate>Wed, 11 Dec 2024 14:06:33 +0000</pubDate>

									<content:encoded><![CDATA[<p>Multiple studies confirm that PARP inhibitors play an important role in killing tumor cells with defects in homologous recombination repair. Its combination with immune checkpoint inhibitors, PI3K/AKT/mTOR pathway inhibitors, cell cycle checkpoint inhibitors, and other drugs can improve the treatment of endometrial cancer.</p>
<p> The study aims to&hellip;<span class="activity-read-more" id="activity-read-more-50813"><a href="https://recash.wpsoul.net/activity/p/50813/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">de7c5136629626a6741f4a085e60e6b1</guid>
				<title>Yildirim Clemensen became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/50706/</link>
				<pubDate>Wed, 11 Dec 2024 13:43:59 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>